19F NMR as a powerful technique for the assay of anti-psychotic drug haloperidol in human serum and pharmaceutical formulations

Journal of Pharmaceutical and Biomedical Analysis

Volumn 43, Issue 3, 2007, Pages 1116-1121

  Shamsipur, Mojtaba ^a   Shafiee Dastgerdi, Leila ^b   Talebpour, Zahra ^c   Haghgoo, Soheila ^d  

^a RAZI UNIVERSITY   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c ALZAHRA UNIVERSITY   (Iran)

^d MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

19F NMR analyses; Degradation; Haloperidol; Pharmaceuticals; Serum

Indexed keywords

HALOPERIDOL; HYDROCHLORIC ACID; NEUROLEPTIC AGENT; TRIFLUOROACETIC ACID; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ARTICLE; DRUG DEGRADATION; DRUG DETERMINATION; DRUG FORMULATION; DRUG ISOLATION; HUMAN; LINEAR SYSTEM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SERUM; STANDARD; BLOOD; CALIBRATION; REPRODUCIBILITY; TABLET;

ANTIPSYCHOTIC AGENTS; CALIBRATION; HALOPERIDOL; HUMANS; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TABLETS;

EID: 33846618704     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.09.038     Document Type: Article

References (35)

1. Remingtons Pharmaceutical Sciences. 18th ed. (1990), Mack, Easton
2. Casey D.E. Curr. Opin. Psychiatr. 4 (1991) 86-89
3. Pangaggio A., and Greene D.S. Drug Dev. Ind. Pharm. 9 (1983) 485-492
4. Janicki C.A., and Ko C.Y. Analytical Profiles of Drug Substances (1980), Academic Press, New York
5. Demon P.J.A.W. J. Pharm. Sci. 50 (1961) 350-353
6. The United States Pharmacopeia (USP) vol. 22 (1990), US Pharmacopeial Convention, Rockville, MD
7. British Pharmacopoeia (BP) vol. 2 (1993), Her Majesty's Stationery Office, London
8. Ouanas S., Kallel M., Trabelsi H., Safta F., and Bouzouita K. J. Pharm. Biomed. Anal. 17 (1998) 361-364
9. Baeyens W., and DeMoerloose P. Pharmazie 32 (1977) 764-771
10. Janicki C.A., and Almond Jr. H.R. J. Pharm. Sci. 63 (1974) 41-43
11. Shingbal D.M., and Josphi S.V. Indian Drugs 22 (1985) 326-329
12. Vire J.C., Fischer M., and Patriache C.J. Analysis 10 (1982) 19-22
13. Kurzawa M., Kowalczyk-Marzec A., and Szlyk E. Chem. Anal. 49 (2004) 91-99
14. Turczan J.W., and Lau-Cam C.A. Drug Dev. Ind. Pharm. 15 (1989) 107-115
15. Krzek J., and Maslanka A. Acta Pol. Pharm. 57 (2000) 23-26
16. Yokogawa K., Nakashima E., Ichimura F., and Yamana T. Chem. Pharm. Bull. 33 (1985) 4581-4586
17. Sane R.T., Gangrade M.G., Bapat V.V., Surve S.R., and Chonkar N.L. Indian Drugs 30 (1993) 205-210
18. Trabelsi H., Raouafi F., Saddem A., and Bouzouita K. J. Pharm. Belg. 52 (1997) 145-148
19. Xu X., and Stewart J.T. J. Liq. Chromatogr. 22 (1999) 1857-1866
20. Pucci V., Raggi M.A., and Kenndler E. J. Liq. Chromatogr. 23 (2000) 25-34
21. Titier K., Bouchet S., Pehourcq F., Moore N., and Molimard M. J. Chromatogr. B 788 (2003) 179-185
22. Yasui-Furukori N., Inoue Y., Chiba M., and Tateishi T. J. Chromatogr. B 805 (2004) 175-180
23. Arinobu T., Hattori H., Iwai M., Ishii A., Kumazawa T., Suzuki O., and Seno H. J. Chromatogr. B 776 (2002) 107-113
24. Driouich R., Takayanagi T., Oshima M., and Motomizu S. J. Chromatogr. A 903 (2000) 271-278
25. Driouich R., Trabelsi H., and Bouzouita K. Chromatographia 53 (2001) 629-634
26. Hull W.E., Port R.E., Hermann R., Britsch B., and Kunz W. Cancer Res. 48 (1988) 1680-1688
27. Holzgrade U., Diel B.W.K., and Wawer I. J. Pharm. Biomed. Anal. 17 (1998) 557-616
28. Martino R., Gilard V., Desmoulin F., and Malet-Martino M. J. Pharm. Biomed. Anal. 38 (2005) 871-891
29. Malet-Martino M., Gilard V., Demoulin F., and Martino R. Clin. Chim. Acta 366 (2006) 61-73
30. Matthews D.B., Hinton R.H., Wright B., Wilson I.D., and Stevenson D. J. Chromatogr. B 695 (1997) 279-285
31. Lenz E.M., Wilson I.D., Wright B., Partridge E.A., Rodgers C.T., Haycock P.R., Lindon J.C., and Nicholson J.K. J. Pharm. Biomed. Anal. 28 (2002) 31-43
32. Shamsipur M., Talebpour Z., and Haghgoo S. Anal. Biochem. 323 (2003) 205-210
33. The United States Pharmacopoeia. 23rd revision (1995), Rand McNally, Taunton, MA
34. Trabelsi H., Bouabdallah S., Bouzouita K., and Safta F. J. Pharm. Biomed. Anal. 29 (2002) 649-657
35. Monkhouse D.C., Campen L.V., and Aguiar A.J. J. Pharm. Sci. 62 (1973) 576-580